{"nct_id":"NCT01668654","title":"Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS","status":"TERMINATED","status_verified_date":"2020-10","start_date":"2012-09-04","start_date_type":"ACTUAL","primary_completion_date":"2013-06-18","primary_completion_date_type":"ACTUAL","completion_date":"2013-06-18","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}